Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

KETAN D DOSHI

Allopathic & Osteopathic Physicians Internal Medicine Medical Oncology

NPI
1750573069
CMS profile
351845
Location
OCALA, FL

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2024 · Entire year

$17,642.92

199 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

Other CMS categories — not shown on this page

Research Payments

CMS also publishes Research Payments as a separate dataset. This site does not currently mirror it, and no research figure is shown on this page. This provider appears in that dataset.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

These records are published by CMS and can be viewed on this provider’s official CMS record. View this provider on CMS Open Payments ↗

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2024 · entire year · sorted by reported total

Nature of paymentAmountRecords
Consulting Fee $11,820.00 7
Food and Beverage $3,912.04 179
Travel and Lodging $1,039.29 4
Long term medical supply or device loan $797.60 8
Education $73.99 1

By paying entity

PY2024 · entire year · sorted by reported total

Paying entityAmountRecords
AstraZeneca Pharmaceuticals LP $5,849.78 21
Novartis Pharmaceuticals Corporation $3,134.18 25
Janssen Biotech, Inc. $2,654.20 10
BeiGene USA, Inc. $2,357.50 6
Daiichi Sankyo Inc. $667.31 11
PFIZER INC. $308.03 14
Celgene Corporation $260.73 15
Takeda Pharmaceuticals U.S.A., Inc. $202.36 10
Merck Sharp & Dohme LLC $178.09 8
E.R. Squibb & Sons, L.L.C. $136.49 6
Novocure Inc. $132.68 3
Janssen Pharmaceuticals, Inc $124.75 1
Gilead Sciences, Inc. $123.40 6
Bayer Healthcare Pharmaceuticals Inc. $122.14 5
JAZZ PHARMACEUTICALS INC. $105.65 3
Lilly USA, LLC $105.43 4
GlaxoSmithKline, LLC. $101.36 5
Eisai Inc. $101.33 4
Mirati Therapeutics, Inc. $85.56 4
Incyte Corporation $78.60 3
Amneal Pharmaceuticals LLC $74.01 3
ABBVIE INC. $59.32 2
ARRAY BIOPHARMA INC $58.12 3
SUN PHARMACEUTICAL INDUSTRIES INC. $46.67 1
Pharmacosmos Therapeutics Inc. $39.43 2
Astellas Pharma US Inc $38.39 2
Regeneron Healthcare Solutions, Inc. $37.07 1
Genmab U.S., Inc. $34.48 1
Aveo Pharmaceuticals, Inc. $26.89 1
Octapharma USA, Inc. $26.45 1
CSL Behring $25.66 1
Genentech USA, Inc. $25.58 1
GENZYME CORPORATION $24.90 1
Kite Pharma, Inc. $24.52 1
Apellis Pharmaceuticals, Inc. $23.54 1
Tempus AI, Inc $23.25 1
Ipsen Biopharmaceuticals, Inc $22.81 1
EMD Serono, Inc. $21.44 1
ADC Therapeutics America, Inc. $21.26 1
PUMA BIOTECHNOLOGY, INC. $20.84 1
Alexion Pharmaceuticals, Inc. $19.92 1
Menarini Silicon Biosystems, Inc. $19.72 1
SERVIER PHARMACEUTICALS LLC $19.15 1
TerSera Therapeutics LLC $18.75 1
Coherus Biosciences Inc. $17.81 1
Exelixis Inc. $15.44 1
Kyowa Kirin, Inc. $14.32 1
Stemline Therapeutics Inc. $13.61 1

Payment records · PY2024

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2024 · Physicians and non-physician practitioners · CMS publication 2026-06-30

199 matching records · $17,642.92 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 199 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 1–50 of 199.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Menarini Silicon Biosystems, Inc. $19.7212/30/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261100676150 CMS
GlaxoSmithKline, LLC. $16.0912/17/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261116204126 CMS
Exelixis Inc. $15.4412/13/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261138560550 CMS
Janssen Biotech, Inc. $1,260.0012/13/2024 Consulting Fee No dispute reported Delay: No
Change: NEW
06/30/20261155140592 CMS
Janssen Biotech, Inc. $1,260.0012/13/2024 Consulting Fee No dispute reported Delay: No
Change: NEW
06/30/20261155140594 CMS
Merck Sharp & Dohme LLC $17.7712/12/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261141752546 CMS
TerSera Therapeutics LLC $18.7512/11/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261144716303 CMS
Celgene Corporation $26.5012/10/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261101188425 CMS
Novartis Pharmaceuticals Corporation $99.7012/10/2024 Long term medical supply or device loan No dispute reported Delay: No
Change: UNCHANGED
06/30/20261086862303 CMS
Novartis Pharmaceuticals Corporation $18.0812/10/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261086862305 CMS
Gilead Sciences, Inc. $24.0412/06/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261133831079 CMS
Novocure Inc. $18.7912/06/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261123336780 CMS
BeiGene USA, Inc. $16.8512/04/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261120860417 CMS
Daiichi Sankyo Inc. $2.7312/04/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261089416682 CMS
Daiichi Sankyo Inc. $21.8712/03/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261089416684 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2.8212/03/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261144956757 CMS
Takeda Pharmaceuticals U.S.A., Inc. $31.4712/03/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261144956759 CMS
AstraZeneca Pharmaceuticals LP $23.5212/02/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261105817387 CMS
Novartis Pharmaceuticals Corporation $20.9111/25/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261086862299 CMS
Novartis Pharmaceuticals Corporation $11.7211/22/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261086862301 CMS
PFIZER INC. $21.8211/20/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261131384020 CMS
PFIZER INC. $0.9211/20/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261131388561 CMS
Novartis Pharmaceuticals Corporation $99.7011/14/2024 Long term medical supply or device loan No dispute reported Delay: No
Change: UNCHANGED
06/30/20261086862293 CMS
Janssen Biotech, Inc. $22.3011/13/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261078460715 CMS
SUN PHARMACEUTICAL INDUSTRIES INC. $46.6711/12/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261152169424 CMS
AstraZeneca Pharmaceuticals LP $1,925.0011/06/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261104689406 CMS
AstraZeneca Pharmaceuticals LP $2,475.0011/06/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261105419109 CMS
Lilly USA, LLC $28.0411/06/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261135107869 CMS
AstraZeneca Pharmaceuticals LP $50.0011/04/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261105725795 CMS
AstraZeneca Pharmaceuticals LP $340.1211/04/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/20261105788912 CMS
GlaxoSmithKline, LLC. $22.1311/04/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261116217894 CMS
AstraZeneca Pharmaceuticals LP $340.1211/02/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/20261104199705 CMS
AstraZeneca Pharmaceuticals LP $336.5511/02/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/20261104704095 CMS
AstraZeneca Pharmaceuticals LP $50.0711/02/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261105324436 CMS
AstraZeneca Pharmaceuticals LP $34.5511/02/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261105448055 CMS
AstraZeneca Pharmaceuticals LP $22.5011/02/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/20261105828723 CMS
Daiichi Sankyo Inc. $525.0011/02/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261084193878 CMS
ABBVIE INC. $30.7711/01/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261103655206 CMS
Daiichi Sankyo Inc. $2.7010/30/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261089416676 CMS
Daiichi Sankyo Inc. $17.1910/29/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261089416678 CMS
Gilead Sciences, Inc. $19.5310/29/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261133831077 CMS
BeiGene USA, Inc. $14.6210/24/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261120860415 CMS
E.R. Squibb & Sons, L.L.C. $21.6710/24/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261101800885 CMS
Novartis Pharmaceuticals Corporation $34.1010/21/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261086862297 CMS
Amneal Pharmaceuticals LLC $19.9410/17/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261139184326 CMS
Novartis Pharmaceuticals Corporation $99.7010/17/2024 Long term medical supply or device loan No dispute reported Delay: No
Change: UNCHANGED
06/30/20261086862295 CMS
Takeda Pharmaceuticals U.S.A., Inc. $18.4610/16/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261144956755 CMS
Stemline Therapeutics Inc. $13.6110/15/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261142961285 CMS
Lilly USA, LLC $18.0110/04/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261135108631 CMS
SERVIER PHARMACEUTICALS LLC $19.1510/03/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261147261204 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $22,329.56 243
PY2020 $15,953.99 116
PY2021 $13,460.05 156
PY2022 $23,637.18 228
PY2023 $11,303.60 179
PY2024 $17,642.92 199
PY2025 $14,897.53 193

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Cite this record.

Plain
KETAN D DOSHI, NPI 1750573069. IndustryPayments, data edition 2026-07-26T04:22:22Z. https://industrypayments.org/provider/npi-1750573069.
APA 7
IndustryPayments. (2026). KETAN D DOSHI, NPI 1750573069 (Data edition 2026-07-26T04:22:22Z) [Data set]. https://industrypayments.org/provider/npi-1750573069
Bluebook
KETAN D DOSHI, NPI 1750573069, IndustryPayments (data edition 2026-07-26T04:22:22Z), https://industrypayments.org/provider/npi-1750573069.

Source: Centers for Medicare & Medicaid Services, Open Payments.